Planning system operations to meet NOX constraints von HESS, S. W, PARKER, D, AMLS, J. E, LE, K. D, DAY, J. T, MALONE, M. J

Volltext

Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: long-term follow-up of the AML17 trial von Russell, Nigel, Burnett, Alan, Hills, Robert, Betteridge, Sophie, Dennis, Mike, Jovanovic, Jelena, Dillon, Richard, Grimwade, David

Volltext

Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO) von Nagel, Gabriele, Weber, D., Fromm, E., Erhardt, S., Lübbert, M., Fiedler, W., Kindler, T., Krauter, J., Brossart, P., Kündgen, A., Salih, H. R., Westermann, J., Wulf, G., Hertenstein, B., Wattad, M., Götze, K., Kraemer, D., Heinicke, T., Girschikofsky, M., Derigs, H.G., Horst, H. A., Rudolph, C., Heuser, M., Göhring, G., Teleanu, V., Bullinger, L., Thol, F., Gaidzik, V. I., Paschka, P., Döhner, K., Ganser, A., Döhner, Hartmut, Schlenk, R. F.

Volltext

The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results... von Burnett, A K, Hills, R K, Hunter, A E, Milligan, D, Kell, W J, Wheatley, K, Yin, J, McMullin, M F, Dignum, H, Bowen, D, Russell, N H

Volltext

High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia von Löwenberg, Bob, Ossenkoppele, Gert J, van Putten, Wim, Schouten, Harry C, Graux, Carlos, Ferrant, Augustin, Sonneveld, Pieter, Maertens, Johan, Jongen-Lavrencic, Mojca, von Lilienfeld-Toal, Marie, Biemond, Bart J, Vellenga, Edo, Kooy, Marinus van Marwijk, Verdonck, Leo F, Beck, Joachim, Döhner, Hartmut, Gratwohl, Alois, Pabst, Thomas, Verhoef, Gregor

Volltext

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG von Lengfelder, E, Haferlach, C, Saussele, S, Haferlach, T, Schultheis, B, Schnittger, S, Ludwig, W-D, Staib, P, Aul, C, Grüneisen, A, Kern, W, Reichle, A, Serve, H, Berdel, W E, Braess, J, Spiekermann, K, Wörmann, B, Sauerland, M-C, Heinecke, A, Hiddemann, W, Hehlmann, R, Büchner, T

Volltext

The prognostic impact of FLT3-ITD and NPM1 mutation in adult AML is age-dependent in the population-based setting von Juliusson, Gunnar, Jädersten, Martin, Deneberg, Stefan, Lehmann, Sören, Möllgård, Lars, Wennström, Lovisa, Antunovic, Petar, Cammenga, Jörg, Lorenz, Fryderyk, Ölander, Emma, Lazarevic, Vladimir Lj, Höglund, Martin

Volltext

A randomised evaluation of low‐dose cytosine arabinoside (ara‐C) plus tosedostat versus low‐dose ara‐C in older patients with acute myeloid leukaemia: results of the LI‐1 trial... von Dennis, Mike, Hills, Robert, Thomas, Ian, Ariti, Cono, Severinsen, Marianne T., Clark, Richard E., Copland, Mhairi, Russell, Nigel, Kallenbach, Maria, Culligan, Dominic, Duncan, Caroline, Krishnamurthy, Pramila, Cuthbert, Ann, Spanoudakis, Michail, Galvani, David, Berkahn, I., Jasani, Parag, Parker, Anne, Arnold, Claire, Cuthbert, Robert, Finnega, Damien, Pratt, Guy, Cahalin, Paul, Ackroyd, Sam, Protheroe, Rachel, Weinkove, Robert, Ali, Sara, Smith, Mark, Spearing, Ruth, Campbell, Gavin, Hamblin, Mike, Wood, Marion, Pillai, Arvind, Rule, Simon, Neilson, Roderick, Lush, Richard, Swe, Wunna, Chalmers, Isobel, Prahladan, Mahesh, Kwan, Mark, Lyttleton, Matthew, Martin, Alexander M., Saravanamuttu, Kandeepan, Saif, Muhammad, Tholouli, Eleni, Andrews, Vivienne, Jackson, Sharon, Gordon, William, Bowen, Angela, McGrann, Alistair, Mittal, Sajjan, Byrne, Jenny, Das‐Gupta, Emma, Radia, Rohini, Baker, Bart, Kilfoyle, Allanah, Knottenbelt, Elayne, Rinaldi, Ciro, Furby, Darshyani, Alderman, Charles, Belsham, Edward, Corser, Robert, Dignum, Helen, Mohan, Mahalakshmi, Kampman, Peter, Kjeldsen, Lars, Mourek, Jindrich, Nielsen, Ove J., Niemann, Carsten U., Khan, Asif, Sampson, Rebecca, Veale, D, Kottaridis, Panagiotis, Cullis, Jonathan, Grand, Effie, Wandroo, Farooq, O'Brien, David, Nicholson, Toby, Janes, Sarah, Galloway, Mike, Mathew, Susanna, Green, Sarah, Mamadigi, Rajesh, Plews, Diane, Chacko, Joseph, Salim, Rahuman, Allameddine, Allameddine, Greenfield, Hayley, Osborne, David, Hodges, Georgina, Carrington, Patrick, Sadik, Walid, Yung, Lynny, Alvares, Caroline, Goodman, Hugh, Aitchison, Robin, Pattinson, Jonathan, Pushkaran, Beena, Edwards, David, Seale, Jim

Volltext

Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden von Juliusson, G, Abrahamsson, J, Lazarevic, V, Antunovic, P, Derolf, Å, Garelius, H, Lehmann, S, Myhr-Eriksson, K, Möllgård, L, Uggla, B, Wahlin, A, Wennström, L, Höglund, M

Volltext

Acute myeloid leukemia in very old patients von Lazarevic, Vladimir Lj, Bredberg, Anders, Lorenz, Fryderyk, Ölander, Emma, Antunovic, Petar, Cammenga, Jörg, Wennström, Lovisa, Möllgård, Lars, Deneberg, Stefan, Derolf, Åsa, Höglund, Martin, Juliusson, Gunnar

Volltext

A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia von Burnett, A K, Russell, N H, Hills, R K, Kell, J, Nielsen, O J, Dennis, M, Cahalin, P, Pocock, C, Ali, S, Burns, S, Freeman, S, Milligan, D, Clark, R E

Volltext

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B von Schlenk, Richard F, Dohner, Konstanze, Kneba, Michael, Gotze, Katharina, Hartmann, Frank, del Valle, Francesco, Kirchen, Heinz, Koller, Elisabeth, Fischer, Jorg T, Bullinger, Lars, Habdank, Marianne, Spath, Daniela, Groner, Silja, Krebs, Bernhard, Kayser, Sabine, Corbacioglu, Andrea, Anhalt, Andreas, Benner, Axel, Frohling, Stefan, Dohner, Hartmut, German-Austrian AML Study Group (AMLSG)

Volltext

Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine von Pabst, Thomas, Vellenga, Edo, van Putten, Wim, Schouten, Harry C., Graux, Carlos, Vekemans, Marie-Christiane, Biemond, Bart, Sonneveld, Peter, Passweg, Jakob, Verdonck, Leo, Legdeur, Marie-Cecile, Theobald, Matthias, Jacky, Emanuel, Bargetzi, Mario, Maertens, Johan, Ossenkoppele, Gert Jan, Löwenberg, Bob

Volltext

Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial von STELIJES, Matthias, BEELEN, Dietrich W, SPIEKERMANN, Karsten, MÜLLER-TIDOW, Carsten, SERVE, Hubert L, SILLING, Gerda, HIDDEMANN, Wolfgang, BERDEL, Wolfgang E, BÜCHNER, Thomas, KIENAST, Joachim, BRAESS, Jan, SAUERLAND, Maria C, HEINECKE, Achim, BERNING, Bjorna, KOLB, Hans J, HOLLER, Ernst, SCHWERDTFEGER, Rainer, ARNOLD, Renate

Volltext

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia: APL von Schlenk, R F, Fröhling, S, Hartmann, F, Fischer, J Th, Glasmacher, A, del Valle, F, Grimminger, W, Götze, K, Waterhouse, C, Schoch, R, Pralle, H, Mergenthaler, H G, Hensel, M, Koller, E, Kirchen, H, Preiss, J, Salwender, H, Biedermann, H G, Kremers, S, Griesinger, F, Benner, A, Addamo, B, Döhner, K, Haas, R, Döhner, H

Volltext

Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG von Fiegl, M, Unterhalt, M, Kern, W, Braess, J, Spiekermann, K, Staib, P, Grüneisen, A, Wörmann, B, Schöndube, D, Serve, H, Reichle, A, Hentrich, M, Schiel, X, Sauerland, C, Heinecke, A, Rieger, C, Beelen, D, Berdel, W E, Büchner, T, Hiddemann, W

Volltext

Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study von Löwenberg, Bob, Beck, Joachim, Graux, Carlos, van Putten, Wim, Schouten, Harry C., Verdonck, Leo F., Ferrant, Augustin, Sonneveld, Pieter, Jongen-Lavrencic, Mojca, von Lilienfeld-Toal, Marie, Biemond, Bart J., Vellenga, Edo, Breems, Dimitri, de Muijnck, Hilde, Schaafsma, Ron, Verhoef, Gregor, Döhner, Hartmut, Gratwohl, Alois, Pabst, Thomas, Ossenkoppele, Gert J., Maertens, Johan, for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), German Austrian AML Study Group (AMLSG), Swiss Group for Clinical Cancer Research Collaborative Group (SAKK)

Volltext

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients von Dufour, Annika, Schneider, Friederike, Hoster, Eva, Benthaus, Tobias, Ksienzyk, Bianka, Schneider, Stephanie, Kakadia, Purvi M., Sauerland, Maria-Cristina, Berdel, Wolfgang E., Büchner, Thomas, Wörmann, Bernhard, Braess, Jan, Subklewe, Marion, Hiddemann, Wolfgang, Bohlander, Stefan K., Spiekermann, Karsten

Volltext

A comparative assessment of the curative potential of reduced intensity allografts in acute myeloid leukaemia von Russell, N H, Kjeldsen, L, Craddock, C, Pagliuca, A, Yin, J A, Clark, R E, Howman, A, Hills, R K, Burnett, A K

Volltext

Single monosomy as a relatively better survival factor in acute myeloid leukemia patients with monosomal karyotype von Jang, J E, Min, Y H, Yoon, J, Kim, I, Lee, J-H, Jung, C W, Shin, H-J, Lee, W S, Lee, J H, Hong, D-S, Kim, H-J, Kim, H-J, Park, S, Lee, K-H, Jang, J H, Chung, J S, Lee, S M, Park, J, Park, S K, Ahn, J-S, Min, W-S, Cheong, J-W

Volltext